Literature DB >> 17943410

Hypersplenism is related to age of onset of liver disease.

P A McCormick1, S Walker, R Benepal.   

Abstract

BACKGROUND: The aim of this study was to investigate whether hypersplenism is related to the age of onset of liver disease.
METHODS: Hypersplenism was assessed in 84 consecutive cirrhotic patients attending a university hospital liver clinic.
RESULTS: Hypersplenism was present in 78% of patients and severe in 39%. Severe hypersplenism was more common in patients with cystic fibrosis liver disease (88%, P < 0.0001) and autoimmune hepatitis (60%, P = 0.0006) compared to alcoholic cirrhosis (12%). There was a significant correlation between patient age and platelet count r = 0.525, P < 0.0001 in the group as a whole and for the sub-group of patients with autoimmune hepatitis r = 0.54, P = 0.047. There was a negative correlation between age and spleen size r = -0.611, P < 0.0001.
CONCLUSION: Younger patients had lower platelet counts, larger spleens and a higher incidence of hypersplenism suggesting that hypersplenism is significantly related to the age of onset of chronic liver disease.

Entities:  

Mesh:

Year:  2007        PMID: 17943410     DOI: 10.1007/s11845-007-0089-8

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  11 in total

1.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

2.  Splenectomy is contraindicated for thrombocytopenia secondary to portal hypertension.

Authors:  M A el-Khishen; J M Henderson; W J Millikan; M H Kutner; W D Warren
Journal:  Surg Gynecol Obstet       Date:  1985-03

3.  Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

Authors:  E Kenny-Walsh
Journal:  N Engl J Med       Date:  1999-04-22       Impact factor: 91.245

4.  Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease.

Authors:  F N Bashour; J C Teran; K D Mullen
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

Review 5.  Hepatosplenic schistosomiasis. Pathophysiology and treatment.

Authors:  L C Da Silva; F J Carrilho
Journal:  Gastroenterol Clin North Am       Date:  1992-03       Impact factor: 3.806

6.  Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis.

Authors:  S H Shah; P C Hayes; P L Allan; J Nicoll; N D Finlayson
Journal:  Am J Gastroenterol       Date:  1996-12       Impact factor: 10.864

7.  Improved survival outcomes for liver transplantation.

Authors:  A Qasim; P A McCormick; T Tajuddin; M B Zaman; O Traynor; J Hegarty; J Geoghegan
Journal:  Ir Med J       Date:  2007-03

8.  Predictors and implications of severe hypersplenism in patients with cirrhosis.

Authors:  Suthat Liangpunsakul; Brian J Ulmer; Naga Chalasani
Journal:  Am J Med Sci       Date:  2003-09       Impact factor: 2.378

9.  Effect of operations for variceal hemorrhage on hypersplenism.

Authors:  N J Soper; L F Rikkers
Journal:  Am J Surg       Date:  1982-12       Impact factor: 2.565

10.  Effect of portacaval anastomosis on hypersplenism.

Authors:  M G Mutchnick; E Lerner; H O Conn
Journal:  Dig Dis Sci       Date:  1980-12       Impact factor: 3.199

View more
  5 in total

1.  Predictive factors for platelet count after laparoscopic splenectomy in cirrhotic patients.

Authors:  Daisuke Yoshida; Yoshihiro Nagao; Morimasa Tomikawa; Hirofumi Kawanaka; Tomohiko Akahoshi; Nao Kinjo; Hideo Uehara; Naotaka Hashimoto; Makoto Hashizume; Yoshihiko Maehara
Journal:  Hepatol Int       Date:  2011-09-30       Impact factor: 6.047

2.  β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children.

Authors:  Ujjal Poddar; Upender Shava; Surender Kumar Yachha; Jaya Agarwal; Sheo Kumar; Sanjay S Baijal; Anshu Srivastava
Journal:  Hepatol Int       Date:  2014-09-23       Impact factor: 6.047

3.  Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process.

Authors:  John M Gemery; Andrew R Forauer; Anne M Silas; Eric K Hoffer
Journal:  BMC Hematol       Date:  2016-02-09

4.  Predictive power of splenic thickness for post-hepatectomy liver failure in HBV-associated hepatocellular carcinoma patients.

Authors:  Xiang Chen; Heng Zou; Li Xiong; Sheng-Fu Huang; Xiong-Ying Miao; Yu Wen
Journal:  World J Surg Oncol       Date:  2017-12-04       Impact factor: 2.754

5.  Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease.

Authors:  Marketa Dostalikova-Cimburova; Kamila Balusikova; Karolina Kratka; Jitka Chmelikova; Vaclav Hejda; Jan Hnanicek; Jitka Neubauerova; Jana Vranova; Jan Kovar; Jiri Horak
Journal:  J Cell Mol Med       Date:  2014-06-03       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.